Ozempic

As a heat wave grips much of the United States, doctors are warning that people taking GLP-1 medications, such as Ozempic and Wegovy, may face heightened health risks. These drugs can contribute to dehydration, which raises the danger of heat exhaustion and other heat-related illness. Health professionals are advising patients on GLP-1 therapies to drink plenty of fluids, limit strenuous outdoor activity, and watch for warning signs like dizziness and nausea during extreme temperatures.

A new study reports that about one in six children taking GLP-1 medications, such as Ozempic and Wegovy, developed nutritional deficiencies while on the drugs. The findings raise concerns that appetite suppression and reduced intake may leave some children short on key nutrients, prompting calls for closer monitoring of children prescribed these increasingly used weight-loss medications.